Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis

BACKGROUND & AIMS: Progressive fibrosis has been identified as the major predictor of mortality in patients with non-alcoholic fatty liver disease (NAFLD). Several biomarkers are currently being evaluated for their ability to substitute the liver biopsy as the reference standard. Recent clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Erhardtsen, Elisabeth, Rasmussen, Daniel G.K., Frederiksen, Peder, Leeming, Diana Julie, Shevell, Diane, Gluud, Lise Lotte, Karsdal, Morten Asser, Aithal, Guruprasad P., Schattenberg, Jörn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385245/
https://www.ncbi.nlm.nih.gov/pubmed/34466796
http://dx.doi.org/10.1016/j.jhepr.2021.100317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385245/
https://www.ncbi.nlm.nih.gov/pubmed/34466796
http://dx.doi.org/10.1016/j.jhepr.2021.100317

Ejemplares similares